Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $6.58 Million - $7.69 Million
-120,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $5.57 Million - $8.09 Million
120,000 New
120,000 $6.69 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Avalon Global Asset Management LLC Portfolio

Follow Avalon Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Global Asset Management LLC with notifications on news.